A CEO who fakes a stock purchase, delays a phase III trial due to a supposed lack of participants (extremely implausible with n=200), and regularly subtly offers the company for sale through self-promotion. What does that tell you?
Exactly! He knows his strategy will fail.
- Forums
- ASX - By Stock
- CUV
- REPORT JUST DROPPED - Check this out!
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.51%
!
$9.71

REPORT JUST DROPPED - Check this out!, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.71 |
Change
-0.050(0.51%) |
Mkt cap ! $486.1M |
Open | High | Low | Value | Volume |
$9.58 | $9.90 | $9.44 | $919.1K | 94.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 124 | $9.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.71 | 200 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 252 | 9.680 |
5 | 256 | 9.670 |
1 | 55 | 9.660 |
3 | 1303 | 9.650 |
2 | 106 | 9.640 |
Price($) | Vol. | No. |
---|---|---|
9.710 | 268 | 5 |
9.720 | 74 | 2 |
9.730 | 191 | 6 |
9.740 | 396 | 5 |
9.750 | 87 | 3 |
Last trade - 14.49pm 18/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online